Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore
Emergent acquires manufacturing facility from MdBio and land from City of Baltimore for $8.2 million
ROCKVILLE, MD, November 13, 2009 – Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has completed the acquisition of a 55,000 square foot manufacturing facility from MdBio Foundation and the land on which the facility stands from the City of Baltimore [...]
Posted on November 15, 2009 at 9:41 pm by admin · Permalink
· Leave a comment
In: Fuad El-Hibri · Tagged with: Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Martin O'Malley, Maryland, State of Maryland, United States
In: Fuad El-Hibri · Tagged with: Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Martin O'Malley, Maryland, State of Maryland, United States
